2-31091689-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024572.4(GALNT14):c.129+46269A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0617 in 152,292 control chromosomes in the GnomAD database, including 436 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.062 ( 436 hom., cov: 32)
Consequence
GALNT14
NM_024572.4 intron
NM_024572.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.04
Genes affected
GALNT14 (HGNC:22946): (polypeptide N-acetylgalactosaminyltransferase 14) This gene encodes a Golgi protein which is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-Ts) protein family. These enzymes catalyze the transfer of N-acetyl-D-galactosamine (GalNAc) to the hydroxyl groups on serines and threonines in target peptides. The encoded protein has been shown to transfer GalNAc to large proteins like mucins. Alterations in this gene may play a role in cancer progression and response to chemotherapy. [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.125 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0616 AC: 9381AN: 152174Hom.: 432 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9381
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0617 AC: 9396AN: 152292Hom.: 436 Cov.: 32 AF XY: 0.0599 AC XY: 4463AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
9396
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
4463
AN XY:
74482
Gnomad4 AFR
AF:
AC:
0.127528
AN:
0.127528
Gnomad4 AMR
AF:
AC:
0.0372549
AN:
0.0372549
Gnomad4 ASJ
AF:
AC:
0.0680115
AN:
0.0680115
Gnomad4 EAS
AF:
AC:
0.0476099
AN:
0.0476099
Gnomad4 SAS
AF:
AC:
0.0801162
AN:
0.0801162
Gnomad4 FIN
AF:
AC:
0.00997365
AN:
0.00997365
Gnomad4 NFE
AF:
AC:
0.0352177
AN:
0.0352177
Gnomad4 OTH
AF:
AC:
0.0487689
AN:
0.0487689
Heterozygous variant carriers
0
436
872
1309
1745
2181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
201
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at